We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Antitrust Watchdog Forces Drug Divestitures

Law360 (January 19, 2007, 12:00 AM EST) -- To maintain competition in the generic injectable drug market, the U.S. Federal Trade Commission said Thursday that Hospira Inc. has to sell five drugs to acquire rival drug maker Mayne Pharma...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.